Intrahepatic cholangiocellular carcinoma and hepatocellular carcinoma developed after a 6-year sustained virological response to interferon therapy for chronic hepatitis C.

about

Intrahepatic cholangiocellular carcinoma and hepatocellular carcinoma developed after a 6-year sustained virological response to interferon therapy for chronic hepatitis C.

Item

http://www.wikidata.org/entity/Q45270825

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Intrahepatic cholangiocellular ...... erapy for chronic hepatitis C.

@en

Intrahepatic cholangiocellular ...... erapy for chronic hepatitis C.

@nl

type

Item

label

Intrahepatic cholangiocellular ...... erapy for chronic hepatitis C.

@en

Intrahepatic cholangiocellular ...... erapy for chronic hepatitis C.

@nl

prefLabel

Intrahepatic cholangiocellular ...... erapy for chronic hepatitis C.

@en

Intrahepatic cholangiocellular ...... erapy for chronic hepatitis C.

@nl

P1476

Intrahepatic cholangiocellular ...... erapy for chronic hepatitis C.

@en

P2093

Jun-Ichi Kaneko

http://www.w3.org/2001/XMLSchema#string

Junko Nagata

http://www.w3.org/2001/XMLSchema#string

Koichi Shiraishi

http://www.w3.org/2001/XMLSchema#string

Norihiro Kokudo

http://www.w3.org/2001/XMLSchema#string

Norihito Watanabe

http://www.w3.org/2001/XMLSchema#string

Sei-Ichiro Kojima

http://www.w3.org/2001/XMLSchema#string

Shinji Takashimizu

http://www.w3.org/2001/XMLSchema#string

Tatehiro Kagawa

http://www.w3.org/2001/XMLSchema#string

Tetsuya Mine

http://www.w3.org/2001/XMLSchema#string

Yasuhiro Nishizaki

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: A 5-year follow-up of 150 patients

Incidence of primary cholangiocellular carcinoma of the liver in japanese patients with hepatitis C virus-related cirrhosis.

Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma.

Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark.

Effects of a 24-week course of interferon-alpha therapy after curative treatment of hepatitis C virus-associated hepatocellular carcinoma.

Double primary liver cancer (intrahepatic cholangiocarcinoma and hepatocellular carcinoma) in a patient with hepatitis C virus-related cirrhosis.

Cholangiolocellular carcinoma containing hepatocellular carcinoma and cholangiocellular carcinoma, extremely rare tumor of the liver:a case report.

Hepatocellular carcinoma after sustained virologic response in hepatitis C patients without cirrhosis on a pretreatment liver biopsy.

Development of hepatocellular carcinoma in a patient 13 years after sustained virological response to interferon against chronic hepatitis C: a case report.

Recurrence rate and prognosis of patients with hepatocellular carcinoma that developed after elimination of hepatitis C virus RNA by interferon therapy. A closed cohort study including matched control patients.

P2888

s12328-011-0216-y

P304

167-173

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12328-011-0216-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1033168788

http://www.w3.org/2001/XMLSchema#string

P698

26189349

http://www.w3.org/2001/XMLSchema#string

P921

virology